Streetbeat News

Earnings

VINC

Vincerx Pharma reported Q2 losses of $(0.52) per share, a 40.91% improvement from $(0.88) per share losses in the same period last year. The company also reported cash and cash equivalents of $6.68M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:11 am

ACRS

Aclaris Therapeutics reported Q2 earnings per share (EPS) of $(0.42), beating the estimate of $(0.45) by 6.67%. However, the company's sales of $1.87M missed the estimate of $1.90M by 1.63%. The EPS is a 35.48% decrease from last year, while sales increased by 22.32% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:11 am

ELAN

Elanco Animal Health reported strong earnings and raised its 2023 financial guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:11 am

VTRS

Viatris has reaffirmed its FY23 revenue guidance of $15.5B-$16B, which is in line with the consensus of $15.6B. The company also expects an adjusted EBITDA of $5.0B-$5.4B and free cash flow of $2.3B-$2.7B.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:08 am

AXSM

Axsome Therapeutics reported Q2 losses of $(1.54) per share, missing the analyst consensus estimate of $(1.24) by 24.19 percent. This is a 45.28 percent decrease over losses from the same period last year. However, the company reported quarterly sales of $46.70 million, beating the analyst consensus estimate of $40.19 million by 16.20 percent, a 429.48 percent increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:04 am

GOGO

Gogo reported Q2 earnings of $0.67 per share, beating the analyst consensus estimate of $0.13 by 415.38%. This is a 294.12% increase from the same period last year. However, the company's quarterly sales of $103.22 million missed the analyst consensus estimate of $103.25 million by 0.03%, though it's a 5.50% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:04 am

VTRS

Viatris (NASDAQ:VTRS) reported Q2 earnings of $0.75 per share, beating the analyst consensus estimate of $0.71 by 5.92%. However, this is a 14.55% decrease from the same period last year. The company also reported quarterly sales of $3.91 billion, beating the estimate of $3.89 billion by 0.58%, but this is a 4.77% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:03 am

DK

Delek US Hldgs (NYSE:DK) reported Q2 earnings of $1.00 per share, beating the analyst consensus estimate of $0.70 by 42.86%. However, this is a 77.27% decrease from the same period last year. The company also reported quarterly sales of $4.20 billion, beating the estimate of $3.60 billion by 16.67%, but this is a 29.87% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:02 am

GENI

Genius Sports has projected an expansion in its group adjusted EBITDA margins from 5% in 2022 to 13% in 2023.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:02 am

CCLP

CSI Compressco (NASDAQ:CCLP) reported Q2 losses of $(0.02) per share, a 60% improvement from $(0.05) per share YoY. Sales also increased by 14.50% to $96.78 million from $84.52 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 11:01 am